Suppr超能文献

用于正电子发射断层扫描(PET)成像大脑中β-肾上腺素能受体的放射性标记拮抗剂的合成与评价

Synthesis and evaluation of radiolabeled antagonists for imaging of beta-adrenoceptors in the brain with PET.

作者信息

Doze Petra, Elsinga P H, Maas B, Van Waarde A, Wegman T, Vaalburg W

机构信息

PET-Center, Groningen University Hospital, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.

出版信息

Neurochem Int. 2002 Feb;40(2):145-55. doi: 10.1016/s0197-0186(01)00081-x.

Abstract

Five potent, lipophilic beta-adrenoceptor antagonists (carvedilol, pindolol, toliprolol and fluorinated analogs of bupranolol and penbutolol) were labeled with either carbon-11 or fluorine-18 and evaluated for cerebral beta-adrenoceptor imaging in experimental animals. The standard radioligand for autoradiography of beta-adrenoceptors, [125I]-iodocyanopindolol, was also included in this survey. All compounds showed either very low uptake in rat brain or a regional distribution that was not related to beta-adrenoceptors, whereas some ligands did display specific binding in heart and lungs. Apparently, the criteria of a high affinity and a moderately high lipophilicity were insufficient to predict the suitability of beta-adrenergic antagonists for visualization of beta-adrenoceptors in the central nervous system.

摘要

五种强效亲脂性β-肾上腺素能受体拮抗剂(卡维地洛、吲哚洛尔、托利洛尔以及布普洛尔和喷布洛尔的氟化类似物)用碳-11或氟-18进行标记,并在实验动物中评估其用于脑β-肾上腺素能受体成像的效果。本次研究还纳入了用于β-肾上腺素能受体放射自显影的标准放射性配体[125I]-碘氰吲哚洛尔。所有化合物在大鼠脑中的摄取量都非常低,或者其区域分布与β-肾上腺素能受体无关,而一些配体在心脏和肺中确实表现出特异性结合。显然,高亲和力和适度高亲脂性的标准不足以预测β-肾上腺素能拮抗剂用于中枢神经系统β-肾上腺素能受体可视化的适用性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验